| Symbol | BFLY |
|---|---|
| Name | BUTTERFLY NETWORK, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medical Electronics |
| Address | 1600 DISTRICT AVENUE, BURLINGTON, Massachusetts, 01803, United States |
| Telephone | +1 781 - 557-4800 |
| Fax | — |
| — | |
| Website | https://www.butterflynetwork.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001804176 |
| Description | Butterfly Network Inc is an innovative digital health company. It is working towards democratizing medical imaging by making it accessible to everyone around the world and contribute to the aspiration of global health equity. The company has developed a groundbreaking single-probe, whole-body point-of-care ultrasound solution leveraging technology. Additional info from NASDAQ: |
New Form SCHEDULE 13G/A - Butterfly Network, Inc. <b>Filed:</b> 2026-07-27 <b>AccNo:</b> 0002012383-26-002275 <b>Size:</b> 11 KB
Read moreDirector ROTHBERG JONATHAN M 🔴 sold 659.9K shares of Butterfly Network, Inc. (BFLY) at $6.47 ($4.3M) Transaction Date: Jul 22, 2026 | Filing ID: 086681
Read more📋 ROTHBERG JONATHAN M (Director) plans to sell 660K shares of Butterfly Network, Inc. (at $6.47 each, total $4.3M) Filed: Jul 22, 2026 | ID: 000088
Read moreDirector ROTHBERG JONATHAN M 🔴 sold 3.1M shares of Butterfly Network, Inc. (BFLY) at $6.74 ($20.7M) Transaction Date: Jul 17, 2026 | Filing ID: 085497
Read more📋 ROTHBERG JONATHAN M (Director) plans to sell 753K shares of Butterfly Network, Inc. (at $6.73 each, total $5.1M) Filed: Jul 21, 2026 | ID: 000087
Read moreNew Form SCHEDULE 13D/A - Butterfly Network, Inc. <b>Filed:</b> 2026-07-21 <b>AccNo:</b> 0001104659-26-085499 <b>Size:</b> 16 KB
Read moreKu Victor 🔴 sold 48.5K shares of Butterfly Network, Inc. (BFLY) at $6.56 Transaction Date: Jul 20, 2026 | Filing ID: 000262
Read moreDirector DEVIVO JOSEPH 🔴 sold 211.8K shares of Butterfly Network, Inc. (BFLY) at $6.56 ($1.4M) Transaction Date: Jul 20, 2026 | Filing ID: 000260
Read more📋 ROTHBERG JONATHAN M (Director) plans to sell 1.2M shares of Butterfly Network, Inc. (at $6.62 each, total $7.8M) Filed: Jul 20, 2026 | ID: 000086
Read more📋 Doherty John N. (Officer) plans to sell 1 shares of Butterfly Network, Inc. (at $6.56 each, total $6.56) Filed: Jul 20, 2026 | ID: 005293
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT06495528 | Bliss DTx Assessment During Course Care Including Port-A-Catheter Setting | Na | Cancer | Recruiting | 2024-06-12 | 2025-05-12 | ClinicalTrials.gov |
| NCT06394752 | UTERINE EVALUATION FOR THE IDENTIFICATION OF PATHOLOGY. This Study Will Compare… | Na | Hysteroscopy | Unknown | 2024-04-25 | 2025-07-30 | ClinicalTrials.gov |
| NCT05594940 | Heart Failure Monitoring With a Portable Ultrasound Device With Artificial Inte… | — | Congestive Heart Failure | Terminated | 2022-09-21 | 2024-02-23 | ClinicalTrials.gov |
| NCT05324826 | Effectiveness of Handheld Ultrasound for Diagnosing Patients with TMD | — | Temporomandibular Joint Disorders | Completed | 2022-05-16 | 2024-11-01 | ClinicalTrials.gov |
| NCT05295823 | Patient Self Measurement of Post-Void Residual Bladder Volume (PVR) Using Ultra… | Na | Voiding Disorders | Completed | 2022-04-27 | 2022-06-03 | ClinicalTrials.gov |
| NCT05341661 | Butterfly Pivotal Study | Na | BPH (Benign Prostatic Hyperplasia) | Active_Not_Recruiting | 2022-04-07 | 2029-12-31 | ClinicalTrials.gov |
| NCT05119673 | POCUS for Difficult Peripheral Access in the Emergency Department - a RCT | Na | Vascular Access | Completed | 2021-10-22 | 2022-05-11 | ClinicalTrials.gov |
| NCT05330520 | Long Term Safety and Efficacy of Butterfly Medical Prostatic Retraction Device … | Na | BPH | Active_Not_Recruiting | 2021-02-10 | 2027-02-01 | ClinicalTrials.gov |
| NCT03912558 | Pilot Study to Assess the Safety and Efficacy of Butterfly Medical Prostatic Re… | Na | BPH | Completed | 2018-10-29 | 2024-04-01 | ClinicalTrials.gov |
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Butterfly Medical Prostatic Retraction Device ("the Butterfly device") removal/replacement | Device | Approved | BPH | ACTIVE_NOT_RECRUITING | NCT05330520 |
| Butterfly Prostatic Retraction Device | Device | Approved | BPH (Benign Prostatic Hyperplasia) | ACTIVE_NOT_RECRUITING | NCT05341661 |
| Butterfly Prostatic Retraction Device | Device | Approved | BPH (Benign Prostatic Hyperplasia) | ACTIVE_NOT_RECRUITING | NCT05341661 |
| Butterfly portable ultrasound device with abstract bladder images | Device | Approved | Voiding Disorders | COMPLETED | NCT05295823 |
| Butterfly portable ultrasound device with bladder ultrasound images | Device | Approved | Voiding Disorders | COMPLETED | NCT05295823 |
| bi-plane sonographic view to difficult peripheral vascular access using Butterfly iQ+® | Other | Approved | Vascular Access | COMPLETED | NCT05119673 |
| Butterfly Medical Prostatic Retraction Device ("the Butterfly device") removal/replacement | Device | Approved | BPH | RECRUITING | NCT05330520 |
| Hydrosonography | Other | Approved | Hysteroscopy | UNKNOWN | NCT06394752 |
| Visual Saline Infusion | Other | Approved | Hysteroscopy | UNKNOWN | NCT06394752 |
| Pain Management with site standard of care sedation protocol | Other | Approved | Cancer | RECRUITING | NCT06495528 |
| Pain management with BLISS DTx | Other | Approved | Cancer | RECRUITING | NCT06495528 |
| Butterfly device implantation | Device | Approved | BPH | COMPLETED | NCT03912558 |
| Butterfly Network handheld ultrasound | Other | Preclinical | Temporomandibular Joint Disorders | COMPLETED | NCT05324826 |
| Butterfly portable ultrasound device with abstract bladder images | DEVICE | Approved | Voiding Disorders | COMPLETED | NCT05295823 |
| Butterfly portable ultrasound device with bladder ultrasound images | DEVICE | Approved | Voiding Disorders | COMPLETED | NCT05295823 |